TABLE 3.

The tumor-suppressive PD-L1-inhibiting miRs in NSCLC.

miR	Ectopic expression effect on NSCLC development	References
hsa-miR-142-5p	Inhibiting the migration and invasion of cisplatin-resistance NSCLC cells.	(6)
hsa-miR-194-5p	Inhibiting the proliferation and clonogenicity of NSCLC cells	(18)
hsa-miR-326	Inhibiting the migration of NSCLC cells and stimulating inflammation	(17)
hsa-miR-526b-3p	Increasing cisplatin chemosensitivity and decreasing the migration and proliferation of NSCLC cells	(16)
hsa-miR-34a-5p	Inhibiting the proliferation, migration, and invasion and stimulating apoptosis	(45)
hsa-miR-138-5p	Inhibiting the proliferation of NSCLC cells and stimulating inflammation	(20)
hsa-miR-377-3p	Decreasing the cell viability, migration, and invasion of NSCLC cells	(47)
hsa-let-7c-5p	Decreasing the cell viability of NSCLC cells	(48)
hsa-miR-200a-3p	Decreasing the cell viability, migration, and invasion of NSCLC cells	(51)
hsa-miR-200c-3p	Potentiating doxorubicin-induced cytotoxicity in NSCLC cells and stimulating inflammation	(54)
hsa-miR-34c-5p	Decreasing the migration and invasion of NSCLC cells	(56)
hsa-miR-197-3p	Increasing the cisplatin and paclitaxel chemosensitivity of NSCLC	(55)
hsa-miR-200b-3p	Decreasing the migration and invasion of NSCLC cells	(58)